Foundational Science and Mechanisms of Disease

426 questions

All types426 Multiple choice221 Numeric17 Matching95 Ordering93

A 65-year-old male with a history of symptomatic atrial fibrillation presents to the cardiology clinic to optimize his medical regimen. The physician decides to start an oral antiarrhythmic agent to maintain normal sinus rhythm. The selected drug has the following known pharmacokinetic parameters in this patient demographic:

* Volume of distribution ( $V_d$ ): $40$ L
* Systemic clearance ( $CL$ ): $2.5$ L/hr
* Oral bioavailability ( $F$ ): $0.80$ ( $80\%$ )
* Half-life ( $t_{1/2}$ ): $11.1$ hours

The target average steady-state plasma concentration ( $C_{ss}$ ) for optimal efficacy without toxicity is $4.0$ mg/L. The physician plans to prescribe the medication to be taken orally every $12$ hours.

Based on these pharmacokinetic parameters, what is the appropriate single oral maintenance dose that should be administered every $12$ hours?

Show answer & explanation

Answer: 150

Answer

150

To maintain a target steady-state concentration, the rate of drug administration must equal the rate of drug elimination. The elimination rate is the product of clearance (

CL

) and the target steady-state concentration (

C_{ss}

). The required maintenance dose per interval (

\tau

) for an oral drug is calculated using the formula:

MD = \frac{CL \times C_{ss} \times \tau}{F}

. Substituting the given parameters:

\frac{2.5 \text{ L/hr} \times 4.0 \text{ mg/L} \times 12 \text{ hr}}{0.80} = 150

mg.

Step-by-Step Solution

Select the correct pharmacokinetic formula for maintenance dosing.

MD = \frac{CL \times C_{ss} \times \tau}{F}

Maintenance dose depends on clearance (to replace eliminated drug), target concentration, dosing interval, and bioavailability.

Extract the relevant values from the clinical vignette.

CL = 2.5

L/hr,

C_{ss} = 4.0

mg/L,

\tau = 12

hr,

F = 0.80

. The volume of distribution (

V_d = 40

L) and half-life (

t_{1/2} = 11.1

hr) are not needed for this calculation.

Accurate variable selection prevents using extraneous data meant for calculating loading dose or time to steady state.

Substitute the values into the formula and calculate.

MD = \frac{2.5 \text{ L/hr} \times 4.0 \text{ mg/L} \times 12 \text{ hr}}{0.80} = \frac{120 \text{ mg}}{0.80} = 150 \text{ mg}

Yields the required dose per 12-hour interval.

Key Concept

The maintenance dose of a drug is determined primarily by its systemic clearance (

CL

) and the target average steady-state plasma concentration (

C_{ss}

). For oral administration, the dose must be adjusted for bioavailability (

F

) and multiplied by the dosing interval (

\tau

Question 122Question →

During morning rounds on the oncology service, a 71-year-old hospitalized individual is found profoundly lethargic and diaphoric. The patient was admitted two days ago for a core needle biopsy of a massive right-sided pleural mass that occupies the lower two-thirds of the hemithorax. Point-of-care capillary blood glucose is 32 mg/dL. A stat venous blood draw is obtained before the administration of intravenous dextrose, which rapidly restores the patient's normal sensorium. The laboratory results from the hypoglycemic episode return as follows:

Plasma glucose: 35 mg/dL
Serum insulin: < 1.0 µU/mL (Normal: 3-25 µU/mL)
Serum C-peptide: 0.1 ng/mL (Normal: 1.1-4.4 ng/mL)
Serum beta-hydroxybutyrate: 0.1 mmol/L (Normal: < 0.4 mmol/L)
Serum growth hormone (GH): < 0.1 ng/mL (Normal: 0.4-10 ng/mL)
Serum insulin-like growth factor 1 (IGF-1): 22 ng/mL (Normal: 70-250 ng/mL)

Which of the following cellular or biochemical mechanisms best explains this patient's clinical presentation and laboratory profile?

Binding of a high-molecular-weight somatomedin to insulin receptors and concurrent suppression of pituitary somatotrophs

Autonomous exocytosis of zinc-coordinated insulin hexamers from a neuroendocrine neoplasm

Pharmacologic blockade of ATP-sensitive potassium channels causing uninhibited endogenous incretin action

Inherited deficiency of carnitine palmitoyltransferase leading to impaired mitochondrial beta-oxidation

Medication-induced inhibition of hepatic glycogenolysis via antagonism of beta-2 adrenergic receptors

Show answer & explanation

Answer: Binding of a high-molecular-weight somatomedin to insulin receptors and concurrent suppression of pituitary somatotrophs

Answer

Binding of a high-molecular-weight somatomedin to insulin receptors and concurrent suppression of pituitary somatotrophs

The correct answer identifies the mechanism of non-islet cell tumor hypoglycemia (NICTH), which classically occurs with large mesenchymal tumors such as solitary fibrous tumors of the pleura (known as Doege-Potter syndrome). These tumors overproduce an incompletely processed form of IGF-2 (a somatomedin) known as 'big IGF-2'. Big IGF-2 binds with high affinity to insulin receptors (specifically the IR-A isoform). This binding mediates profound hypoglycemia and inhibits lipolysis, which explains the inappropriately low beta-hydroxybutyrate (ketone) levels. Furthermore, big IGF-2 crosses the blood-brain barrier and exerts negative feedback on the hypothalamus and pituitary gland, suppressing growth hormone (GH) secretion. The chronically low GH leads to decreased hepatic production of IGF-1 and IGF-binding proteins, further increasing the amount of free, metabolically active big IGF-2 in circulation. This creates the classic laboratory profile seen here: suppressed insulin, C-peptide, ketones, GH, and IGF-1 in the setting of severe fasting hypoglycemia.

Step-by-Step Solution

Analyze the basic metabolic state from the labs.

The patient has severe hypoglycemia (35 mg/dL) with undetectable insulin and C-peptide.

This immediately rules out exogenous insulin administration (would have high insulin) and endogenous hyperinsulinism like insulinoma or sulfonylurea use (would have high C-peptide).

Evaluate counter-regulatory hormone response and ketone levels.

Beta-hydroxybutyrate is very low (hypoketotic), and GH/IGF-1 are profoundly suppressed.

Normally, non-insulin-mediated hypoglycemia should trigger massive lipolysis (high ketones) and a surge in counter-regulatory hormones like GH. The suppression of lipolysis and GH points to an insulin-like substance acting systemically.

Correlate metabolic findings with the clinical presentation (massive pleural mass).

The combination of a large mesenchymal tumor, hypoketotic hypoglycemia, low insulin, and low GH/IGF-1 is diagnostic of non-islet cell tumor hypoglycemia (NICTH), specifically Doege-Potter syndrome.

These tumors secrete incompletely processed Insulin-like Growth Factor 2 (Big IGF-2). Big IGF-2 activates insulin receptors (causing hypoglycemia and preventing ketogenesis) and suppresses pituitary GH secretion (lowering IGF-1).

Key Concept

Pathophysiology of Non-Islet Cell Tumor Hypoglycemia (NICTH) via Big IGF-2

Question 123Question →

Match each patient's clinical presentation with the specific host cell receptor targeted by the responsible viral pathogen.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Parvovirus B19 matches with Erythrocyte P antigen; EBV matches with CD21; Rabies virus matches with nAChR; Rhinovirus matches with ICAM-1; and SARS-CoV-2 matches with ACE2.

Each vignette describes a distinct viral infection characterized by a highly specific host cellular receptor required for initial pathogenesis. Parvovirus B19 targets the P antigen on erythroid precursors; Epstein-Barr Virus targets CD21 on B cells; Rabies virus targets the nicotinic acetylcholine receptor at the neuromuscular junction; Rhinovirus targets ICAM-1 on respiratory epithelium; and SARS-CoV-2 targets ACE2 on pneumocytes.

Step-by-Step Solution

Identify the underlying viral pathogen responsible for the clinical syndrome described in each vignette.

Vignette 1 = Parvovirus B19; Vignette 2 = Epstein-Barr virus; Vignette 3 = Rabies virus; Vignette 4 = Rhinovirus; Vignette 5 = SARS-CoV-2.

Recognizing the classic clinical presentation is required before determining the specific molecular mechanism of cellular infection.

Determine the specific host cell receptor utilized by each identified virus for cellular attachment and entry.

Parvovirus B19 utilizes the P antigen; EBV utilizes CD21; Rabies virus utilizes the nicotinic acetylcholine receptor; Rhinovirus utilizes ICAM-1; SARS-CoV-2 utilizes ACE2.

Viral tropism is primarily dictated by the physical interaction between viral surface glycoproteins or capsids and complementary host cell receptors.

Key Concept

Viral tropism and the resulting clinical pathogenesis are fundamentally determined by the ability of specific viral surface proteins to bind distinct host cell receptors.

Question 124Question →

Following a recent medical mission in Southeast Asia where she sustained an accidental needlestick injury, a 24-year-old woman develops progressive fatigue, right upper quadrant abdominal pain, and dark urine. Physical examination confirms marked scleral icterus and a tender, palpable liver edge. Laboratory studies reveal severely elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), alongside positive serologies for Hepatitis B surface antigen (HBsAg) and IgM anti-HBc. A liver biopsy is obtained to evaluate the extent of injury, demonstrating scattered shrunken, intensely eosinophilic cells with fragmented nuclei, known as Councilman bodies. The targeted elimination of these infected hepatocytes is primarily driven by cytotoxic T lymphocytes.

Arrange the following subcellular events in the correct chronological sequence that leads to the specific histological findings described in this patient's liver biopsy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Binding of Fas ligand to CD95 -> Oligomerization of death domains -> Recruitment of FADD -> Cleavage of procaspase-8 -> Activation of executioner caspases.

The clinical vignette describes a patient with acute Hepatitis B viral infection. The liver biopsy reveals Councilman bodies, which represent apoptotic hepatocytes. In viral hepatitis, infected cells are cleared by CD8+ cytotoxic T lymphocytes. One of the primary mechanisms by which CD8+ T cells induce apoptosis in target cells is the extrinsic pathway via Fas ligand (FasL). The correct chronological sequence of this cascade begins with the T cell's FasL binding to the Fas receptor (CD95) on the hepatocyte. This interaction induces trimerization of the receptor's intracellular death domains. The clustered death domains act as a docking site for the adapter protein FADD (Fas-associated death domain). FADD then recruits procaspase-8, leading to its proximity-induced auto-catalytic cleavage into active caspase-8. Finally, initiator caspase-8 cleaves and activates executioner caspases (such as caspase-3), which activate endonucleases and proteases that dismantle the cell, resulting in the characteristic shrunken, eosinophilic appearance of the Councilman body.

Step-by-Step Solution

Diagnose the clinical condition and mechanism of injury.

The patient has acute Hepatitis B with liver biopsy showing Councilman bodies, which are apoptotic hepatocytes killed by CD8+ cytotoxic T cells.

Identifying the mechanism (apoptosis via T-cells) is required to determine which cellular cascade is active.

Identify the specific apoptotic pathway utilized by cytotoxic T cells.

Cytotoxic T cells induce apoptosis in target cells primarily through the extrinsic Fas/FasL death receptor pathway or the perforin/granzyme pathway. The items listed correspond to the Fas/FasL cascade.

Distinguishing between the intrinsic (mitochondrial) and extrinsic (receptor-mediated) pathways is necessary to sequence the molecular events.

Sequence the molecular events of the extrinsic apoptosis pathway.

FasL binds to Fas (CD95) -> Receptors trimerize -> FADD is recruited -> Procaspase-8 auto-cleaves -> Executioner caspases (caspase-3) activate endonucleases.

This is the exact biochemical signaling cascade that translates extracellular immune recognition into programmed cell death.

Key Concept

The extrinsic (death receptor) pathway of apoptosis is initiated by FasL binding to Fas (CD95), leading to FADD recruitment, caspase-8 activation, and subsequent executioner caspase-mediated cell death (e.g., Councilman bodies in viral hepatitis).

Question 125Question →

A 42-year-old woman is evaluated for a recurrence of high-grade serous ovarian carcinoma. She has a strong family history of breast and ovarian malignancies and is known to carry a deleterious germline mutation in the BRCA1 gene. Her oncologist initiates therapy with olaparib, an oral targeted agent that exploits the principle of synthetic lethality. Arrange the following molecular and cellular events in the correct chronological sequence that mediates the antineoplastic efficacy of this pharmacological intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with the pharmacologic inhibition of base excision repair, followed by the conversion of single-strand breaks to double-strand breaks during replication, the failure of homologous recombination, the forced reliance on error-prone non-homologous end joining, and ultimately, fatal genomic instability.

Synthetic lethality occurs when the simultaneous disruption of two genes/pathways leads to cell death, whereas the disruption of either alone is non-lethal. Here, the tumor has a baseline defect in homologous recombination (HR) due to the BRCA1 mutation. When olaparib inhibits PARP (blocking base excision repair), single-strand DNA breaks accumulate. During DNA replication, these single-strand breaks stall replication forks, converting them into double-strand breaks. Because the tumor lacks HR, it cannot repair these double-strand breaks accurately. It relies on the error-prone non-homologous end joining (NHEJ) pathway, which results in devastating chromosomal rearrangements, mitotic catastrophe, and apoptosis.

Step-by-Step Solution

Identify the primary molecular target of the drug.

Olaparib inhibits PARP, blocking base excision repair and causing single-strand DNA breaks to accumulate.

Understanding the direct pharmacodynamic action of the drug establishes the first event in the cascade.

Determine the downstream consequence of the primary target inhibition.

Single-strand breaks are converted into double-strand breaks during the S phase of the cell cycle.

Single-strand breaks are not immediately lethal; they become lethal double-strand breaks when replication forks collapse.

Relate the patient's genetic profile to the molecular cascade.

The BRCA1 mutation prevents the cell from using homologous recombination to repair the newly formed double-strand breaks.

This step defines the tumor-specific vulnerability required for synthetic lethality.

Identify the cellular compensatory mechanism.

The cell utilizes error-prone non-homologous end joining as a desperate attempt to repair the DNA.

Cells possess backup repair pathways, which are activated when the primary high-fidelity pathway is defective.

Determine the ultimate cellular outcome.

Error-prone repair causes massive genomic instability, leading to mitotic catastrophe and apoptosis.

This is the final terminal event that achieves the clinical antineoplastic effect.

Key Concept

Mechanisms of synthetic lethality, specifically PARP inhibition in homologous recombination-deficient (BRCA-mutated) neoplasms.

Question 126Question →

A 48-year-old woman is admitted to the hospital with a massive left iliofemoral deep vein thrombosis. She is immediately started on an intravenous infusion of unfractionated heparin, and oral warfarin is initiated on the same day. Her past medical history is significant for two prior unprovoked lower extremity deep vein thromboses in her 30s. On hospital day 3, she complains of severe pain over her anterior thighs and abdomen. Physical examination reveals several large, well-demarcated, erythematous plaques that rapidly progress to purpuric, necrotic eschars over the next 12 hours. Laboratory studies show a platelet count of 245,000/mm³ (baseline 250,000/mm³), a prothrombin time (PT) of 22 seconds, and an activated partial thromboplastin time (aPTT) of 65 seconds. Which of the following underlying conditions most strongly predisposed this patient to develop this specific cutaneous complication?

Inherited deficiency of an endogenous anticoagulant factor with a short circulating half-life

Production of IgG autoantibodies directed against complexes of a drug and a platelet protein

Resistance of an activated procoagulant factor to proteolytic degradation

Reduced baseline levels of a serine protease inhibitor that complexes with a glycosaminoglycan

Dislodgement of atheromatous debris from the aorta following systemic anticoagulation

Show answer & explanation

Answer: Inherited deficiency of an endogenous anticoagulant factor with a short circulating half-life

Answer

Inherited deficiency of an endogenous anticoagulant factor with a short circulating half-life

The correct answer identifies an inherited deficiency of Protein C, an endogenous anticoagulant that requires vitamin K for its synthesis. Warfarin works by inhibiting the enzyme vitamin K epoxide reductase, which prevents the gamma-carboxylation of procoagulant factors II, VII, IX, and X, as well as the anticoagulant proteins C and S. Because Protein C has a very short biological half-life (approximately 8 hours) compared to Factor II (approximately 72 hours), initiating warfarin causes Protein C levels to plummet first. This leads to a transient, paradoxical hypercoagulable state. In patients who already have an underlying, inherited Protein C deficiency (which is highly likely in a young patient with multiple unprovoked DVTs), this transient hypercoagulable state is severely exaggerated, leading to diffuse microvascular thrombosis in adipose tissue and subsequent skin necrosis.

Step-by-Step Solution

Analyze the patient's clinical presentation and timeline.

The patient developed painful, purpuric, necrotic eschars on her thighs and abdomen 3 days after starting warfarin and heparin. Her platelet count remains normal.

Establishing the timeline and key physical findings helps differentiate among adverse drug reactions.

Identify the specific cutaneous complication.

The clinical picture of rapid-onset skin necrosis in adipose-rich areas shortly after initiating warfarin is diagnostic of warfarin-induced skin necrosis.

Matching the classic physical exam findings with the pharmacologic timeline allows for accurate diagnosis.

Determine the pathophysiologic mechanism and predisposing factors.

Warfarin causes a rapid drop in Protein C levels before procoagulant factors are depleted. Patients with an underlying, inherited Protein C deficiency are at the highest risk for this exaggerated transient hypercoagulable state.

The question asks for the underlying condition predisposing the patient to this exact complication, requiring knowledge of coagulation factor half-lives.

Key Concept

Warfarin-induced skin necrosis typically occurs in patients with an underlying Protein C deficiency due to the rapid, disproportionate depletion of this short-lived anticoagulant, which creates a transient hypercoagulable window.

Estimated Time:1m 30s

Question 127Question →

A $76$ -year-old man is brought to the emergency department by his daughter after he vomited approximately $500$ mL of bright red blood. He has a history of nonvalvular atrial fibrillation, hypertension, and osteoarthritis. His medications include dabigatran, lisinopril, and ibuprofen. For the past $3$ days, he has had a diarrheal illness with poor oral intake. On presentation, he appears pale and diaphoretic. Blood pressure is $86/54$ mm Hg, and pulse is $118$ /min.

Laboratory results are as follows:
- Hemoglobin: $7.2$ g/dL
- Platelet count: $210,000$ /mm $^3$
- Creatinine: $3.4$ mg/dL (baseline $1.2$ mg/dL)
- Prothrombin time (PT): $16$ seconds
- Activated partial thromboplastin time (aPTT): $72$ seconds

The patient is given intravenous crystalloids and packed red blood cells. A specific pharmacologic antidote is administered to rapidly neutralize the circulating anticoagulant. Which of the following best describes the mechanism of action of this antidote?

Binding and neutralization of the anticoagulant by a humanized monoclonal antibody fragment

Sequestration of the anticoagulant by a catalytically inactive recombinant factor Xa analog

Formation of a stable, inactive salt complex via a highly positively charged peptide

Promotion of gamma-carboxylation of glutamic acid residues on specific coagulation factors

Competitive inhibition of plasminogen activation to prevent fibrin degradation

Show answer & explanation

Answer: Binding and neutralization of the anticoagulant by a humanized monoclonal antibody fragment

Answer

Binding and neutralization of the anticoagulant by a humanized monoclonal antibody fragment

This patient presents with a life-threatening gastrointestinal hemorrhage secondary to dabigatran toxicity. His pre-renal acute kidney injury—triggered by volume depletion from diarrhea and exacerbated by concurrent use of lisinopril (efferent arteriole vasodilation) and ibuprofen (afferent arteriole vasoconstriction)—has led to decreased renal clearance and subsequent accumulation of dabigatran. Dabigatran is a direct thrombin (factor IIa) inhibitor. The specific and targeted reversal agent for dabigatran is idarucizumab. Idarucizumab is a humanized monoclonal antibody fragment that binds to both free and thrombin-bound dabigatran with extremely high affinity, rapidly neutralizing its anticoagulant effect.

Step-by-Step Solution

Analyze the patient's clinical presentation and laboratory results.

The patient has life-threatening gastrointestinal bleeding and an elevated creatinine (

3.4

mg/dL from

1.2

mg/dL), indicating acute kidney injury (AKI). Coagulation studies show a significantly prolonged aPTT.

Identifying the severity of bleeding and the presence of AKI helps determine the cause of the coagulopathy.

Correlate the patient's medications with the current clinical picture.

The patient is taking dabigatran, lisinopril, and ibuprofen. The combination of volume depletion (diarrhea), an ACE inhibitor, and an NSAID has caused pre-renal AKI. Dabigatran, a direct thrombin inhibitor, is

80\%

renally cleared and has accumulated, causing toxicity and bleeding.

Understanding the pharmacokinetics of dabigatran is crucial; renal impairment is the primary risk factor for dabigatran toxicity.

Identify the appropriate management and mechanism of action for the targeted reversal agent.

The specific antidote for dabigatran is idarucizumab, which is a humanized monoclonal antibody fragment designed to bind and neutralize dabigatran.

Reversing the specific drug responsible for the hemorrhage is the definitive management step in life-threatening bleeding.

Key Concept

Dabigatran is a direct thrombin inhibitor that is primarily renally excreted; its toxicity in the setting of acute kidney injury is reversed with idarucizumab, a specific humanized monoclonal antibody fragment.

Question 128Question →

A 58-year-old man is hospitalized for an acute myocardial infarction and undergoes percutaneous coronary intervention. He receives an unfractionated heparin infusion as bridging therapy. On hospital day 7, his platelet count falls precipitously from 260,000/mm³ to 85,000/mm³. Concurrently, he complains of acute, severe pain in his left lower extremity, and a venous Doppler ultrasound confirms a new deep vein thrombosis. The patient's 4T score indicates a high clinical probability of heparin-induced thrombocytopenia (HIT). Arrange the following therapeutic management steps in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first discontinue all heparin products, then initiate a direct thrombin inhibitor, subsequently wait for the platelet count to recover to >150,000/mm³, and finally initiate warfarin with an appropriate minimum 5-day overlap period.

Heparin-induced thrombocytopenia (HIT) is a life-threatening, immune-mediated prothrombotic complication. Its management requires strict adherence to a specific sequence of therapeutic interventions to prevent catastrophic thrombotic outcomes such as venous limb gangrene. The absolute first step is the immediate cessation of all heparin exposure to halt the immune cascade. However, because the patient is profoundly hypercoagulable (evidenced by the new DVT), therapeutic anticoagulation must be maintained using a non-cross-reacting agent, typically an intravenous direct thrombin inhibitor (DTI) like argatroban. A critical USMLE concept is the safe management of the transition to long-term oral anticoagulation. Warfarin is strictly contraindicated during the acute, thrombocytopenic phase of HIT. If given while platelets are low, warfarin's rapid depletion of Protein C causes a severe, transient hypercoagulable state that, when superimposed on active HIT, reliably causes extensive microvascular thrombosis and limb gangrene. Therefore, the clinician must wait for the platelet count to recover to at least 150,000/mm³ on the DTI. Only then can warfarin be safely initiated, and it must be continuously overlapped with the DTI for at least 5 days and until the INR is completely therapeutic.

Step-by-Step Solution

Halt the underlying immune trigger.

All forms of heparin (including intravenous infusions, flushes, and coated catheters) are immediately discontinued.

HIT is driven by IgG autoantibodies directed against PF4-heparin complexes; removing all heparin stops the primary antigenic stimulus.

Provide immediate systemic anticoagulation with a safe alternative.

An intravenous direct thrombin inhibitor (e.g., argatroban) is started.

Patients with acute HIT are at extreme risk for devastating arterial and venous thromboses. Continuous therapeutic anticoagulation must be maintained using a non-heparin, non-cross-reacting agent.

Ensure clinical resolution of the acute consumptive process.

The platelet count is meticulously monitored until it normalizes to at least 150,000/mm³.

Premature initiation of warfarin during the acute thrombotic phase of HIT is highly dangerous and strictly contraindicated.

Transition to long-term oral anticoagulation.

Warfarin is started and overlapped with the direct thrombin inhibitor for a minimum of 5 days until a stable, therapeutic INR is achieved.

The overlap prevents the transient hypercoagulable state caused by warfarin's rapid depletion of Protein C (a natural anticoagulant), which can precipitate microvascular thrombosis and venous limb gangrene in HIT patients.

Key Concept

Therapeutic sequencing for Heparin-Induced Thrombocytopenia (HIT), emphasizing the absolute contraindication of early warfarin initiation before platelet recovery.

Question 129Question →

A 28-year-old aid worker recently returned from a disaster relief mission in Southeast Asia. She presents to the emergency department with severe, voluminous watery diarrhea and muscle cramps that began 12 hours ago. Her vital signs show a blood pressure of 86/50 mmHg, heart rate of 124/min, and a respiratory rate of 22/min. Physical examination reveals deeply sunken eyes, dry mucous membranes, and delayed capillary refill. Stool is liquid, pale, and flecked with small amounts of mucus. She is aggressively rehydrated with intravenous crystalloids. The pathogen responsible for this patient's condition exerts its effect through a specific multi-step cellular cascade.

Arrange the following events in the correct chronological order to describe the cellular mechanism of action of the primary enterotoxin produced by the most likely causative organism.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: binding to the GM1 receptor, endocytosis and retrograde transport, ADP-ribosylation of the Gs alpha subunit, constitutive activation of adenylate cyclase, and finally the opening of CFTR channels causing chloride and water efflux.

The correct sequence begins with the cholera toxin's pentameric B subunit binding to the GM1 ganglioside receptor on the apical surface of intestinal epithelial cells. Following attachment, the toxin is internalized via endocytosis and undergoes retrograde transport through the Golgi network to the endoplasmic reticulum. There, the enzymatically active A1 subunit is released into the cytosol. The A1 subunit then catalyzes the ADP-ribosylation of the stimulatory G-protein (Gs) alpha subunit, permanently locking it in the active GTP-bound state. This leads to the constitutive activation of adenylate cyclase and a subsequent rapid accumulation of intracellular cAMP. Finally, the elevated cAMP levels activate protein kinase A, which phosphorylates and opens CFTR chloride channels, resulting in a massive efflux of chloride ions and water into the intestinal lumen. This cascade directly produces the 'rice-water' secretory diarrhea characteristic of cholera.

Step-by-Step Solution

Identify the clinical syndrome and likely pathogen from the vignette.

The patient's presentation of severe, voluminous 'rice-water' diarrhea and profound dehydration after a disaster relief mission is classic for cholera, caused by Vibrio cholerae.

Recognizing the pathogen is necessary to determine the specific virulence factor and its mechanism of action.

Determine the primary virulence factor responsible for the symptoms.

The severe secretory diarrhea is mediated by the cholera toxin (CT), an AB5-type enterotoxin.

Understanding the toxin's classification helps in recalling its specific cellular target and mechanism.

Sequence the cellular mechanism of action of the cholera toxin chronologically.

The sequence is: 1) B subunit binds GM1, 2) Toxin undergoes endocytosis/retrograde transport, 3) A1 subunit ADP-ribosylates Gs alpha, 4) Adenylate cyclase is constitutively activated, 5) CFTR channels open causing fluid efflux.

This step-by-step cascade directly answers the question's requirement to order the mechanism of action.

Key Concept

The pathophysiological mechanism of cholera toxin involves binding to the GM1 ganglioside receptor, retrograde transport, ADP-ribosylation of the Gs alpha subunit, increased intracellular cAMP, and subsequent CFTR-mediated chloride and water secretion.

Estimated Time:1m 30s

Question 130Question →

A clinical pharmacologist is reviewing medication charts for several patients admitted to the internal medicine service. Various drug-related changes in efficacy, toxicity, and duration of action are noted. Identify the underlying pharmacokinetic or pharmacodynamic mechanism that best explains each patient's clinical presentation.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The clinical scenarios map to their respective mechanisms: prolonged sedation in the elderly maps to increased volume of distribution; phenytoin toxicity maps to zero-order kinetics; warfarin failure maps to enzyme induction; and opioid dose escalation maps to pharmacodynamic tolerance.

Each scenario illustrates a fundamental principle of pharmacokinetics or pharmacodynamics. Aging inherently increases body fat percentages, expanding the distribution volume for lipophilic substances and thereby increasing half-life. Phenytoin's saturable metabolism means that once enzymes are working at maximum capacity, any further dose increase cannot be cleared efficiently, leading to rapid toxicity. Carbamazepine transcriptionally upregulates hepatic enzymes, which accelerates the clearance of co-administered drugs like warfarin, rendering them subtherapeutic. Finally, continuous receptor stimulation by opioids causes receptor downregulation, a classic cellular mechanism of pharmacodynamic tolerance.

Step-by-Step Solution

Analyze the geriatric patient receiving a lipophilic drug.

Older adults have a higher percentage of body fat, increasing the volume of distribution (

V_d

) for lipophilic medications and prolonging their half-life.

To identify age-related pharmacokinetic changes in drug distribution.

Evaluate the phenytoin toxicity scenario.

Phenytoin exhibits Michaelis-Menten kinetics. Its metabolic enzymes saturate at therapeutic doses, switching from first-order to zero-order elimination.

To explain the non-linear dose-response relationship in phenytoin toxicity.

Assess the warfarin and carbamazepine interaction.

Carbamazepine induces CYP450 enzymes, which increases the metabolism of warfarin, lowering its concentration and clinical effect.

To identify the mechanism of this specific drug-drug interaction.

Determine the cause of opioid dose escalation.

Chronic opioid use leads to receptor downregulation and desensitization, requiring higher doses for the same effect.

To differentiate pharmacokinetic tolerance from pharmacodynamic tolerance.

Key Concept

Pharmacokinetic and pharmacodynamic principles including alterations in volume of distribution, Michaelis-Menten kinetics, enzyme induction, and pharmacodynamic tolerance.

Question 131Question →

A 51-year-old man is evaluated in the outpatient clinic for an 8-month history of progressive proximal muscle weakness and diffuse bone pain. He reports difficulty climbing stairs and rising from a chair. He recently sustained a right-sided rib fracture from a minor coughing fit. His medical history is significant for gastroesophageal reflux disease, for which he frequently takes over-the-counter aluminum hydroxide. He took a short course of oral bisphosphonates 2 years ago for suspected osteoporosis but discontinued it. Vital signs are within normal limits. Physical examination reveals proximal muscle weakness of the lower extremities and marked tenderness over the ribs, pelvis, and shins.

Laboratory studies show the following:

Test	Result	Reference Range
Serum calcium	9.1 mg/dL	8.4 - 10.2 mg/dL
Serum phosphate	1.6 mg/dL	2.5 - 4.5 mg/dL
Parathyroid hormone (PTH)	45 pg/mL	15 - 65 pg/mL
25-hydroxyvitamin D	38 ng/mL	20 - 50 ng/mL
1,25-dihydroxyvitamin D	12 pg/mL	18 - 72 pg/mL
Alkaline phosphatase	280 U/L	40 - 120 U/L
Serum creatinine	0.8 mg/dL	0.7 - 1.3 mg/dL

Urinalysis reveals a fractional excretion of phosphate of 25% (normal < 5% in the setting of hypophosphatemia). Urine tests for glucose and amino acids are negative.

Which of the following is the most likely primary molecular mechanism responsible for this patient's clinical and laboratory findings?

Secretion of a circulating factor that downregulates renal sodium-phosphate cotransporters

Gastrointestinal binding of dietary phosphate by a heavy metal-containing antacid

Ectopic production of a peptide structurally homologous to parathyroid hormone

Intratubular deposition of monoclonal light chains causing generalized proximal tubular dysfunction

Pharmacologic inhibition of osteoclastic bone resorption leading to impaired bone remodeling

Show answer & explanation

Answer: Secretion of a circulating factor that downregulates renal sodium-phosphate cotransporters

Answer

Secretion of a circulating factor that downregulates renal sodium-phosphate cotransporters

The patient's clinical presentation of progressive bone pain, muscle weakness, and non-traumatic fractures, combined with profound hypophosphatemia, inappropriate phosphaturia, normal calcium, normal PTH, and low 1,25-dihydroxyvitamin D, is the classic biochemical signature of tumor-induced osteomalacia (TIO). TIO is a paraneoplastic syndrome caused by small, often benign mesenchymal tumors that overproduce fibroblast growth factor 23 (FGF23). Under normal physiologic conditions, FGF23 is secreted by osteocytes in response to hyperphosphatemia. It acts on the proximal renal tubule (via the Klotho-FGFR1 complex) to downregulate sodium-phosphate cotransporters (NaPi-IIa and NaPi-IIc), leading to phosphaturia. Crucially, FGF23 also inhibits 1-alpha-hydroxylase (CYP27B1), decreasing the synthesis of active 1,25-dihydroxyvitamin D. This dual action perfectly explains the patient's presentation. The underlying mechanism is the secretion of a circulating factor (FGF23) that downregulates these cotransporters.

Step-by-Step Solution

Interpret the patient's comprehensive metabolic profile.

The profile demonstrates profound hypophosphatemia, excessive renal phosphate wasting (fractional excretion 25%), normal calcium, normal PTH, normal 25-hydroxyvitamin D, and inappropriately low active 1,25-dihydroxyvitamin D.

Establishing the precise combination of biochemical derangements is critical to isolating the specific endocrine defect.

Analyze the relationship between the hypophosphatemia and vitamin D metabolism.

Normally, isolated hypophosphatemia strongly stimulates renal 1-alpha-hydroxylase to increase 1,25-dihydroxyvitamin D. The low 1,25-dihydroxyvitamin D in this patient indicates a pathological suppression of this enzyme.

To rule out gastrointestinal causes of hypophosphatemia (which would present with appropriate renal compensation and high 1,25-dihydroxyvitamin D).

Identify the specific syndrome and underlying molecular mechanism.

The concurrent findings of renal phosphate wasting and suppressed 1-alpha-hydroxylase perfectly characterize fibroblast growth factor 23 (FGF23) excess, typical of tumor-induced osteomalacia (TIO). FGF23 acts on the proximal tubule to downregulate sodium-phosphate cotransporters.

Synthesizing the clinical data points directly to a paraneoplastic circulating factor.

Key Concept

Pathophysiology of Fibroblast Growth Factor 23 (FGF23) in Tumor-Induced Osteomalacia

Question 132Question →

A 42-year-old man presents to the clinic with progressive shortness of breath on exertion and a chronic daily cough. He has a 10-pack-year smoking history but quit 5 years ago. Pulmonary function testing demonstrates an obstructive pattern with a decreased diffusing capacity of the lungs for carbon monoxide (DLCO). Routine laboratory evaluation reveals mildly elevated serum aminotransferases. A subsequent liver biopsy is performed, revealing periodic acid-Schiff (PAS)-positive, diastase-resistant globules in the cytoplasm of periportal hepatocytes. If the accumulated substance in this patient's hepatocytes continues to overwhelm the cellular degradative capacity, which of the following mechanisms will most likely mediate the subsequent cell death?

Activation of the intrinsic apoptotic pathway due to endoplasmic reticulum stress

Disruption of the plasma membrane caused by massive cytosolic calcium influx

Depletion of intracellular glutathione leading to reactive oxygen species accumulation

Activation of the extrinsic apoptotic pathway via death receptor-ligand binding

Lipid peroxidation of cellular membranes by Fenton reaction products

Show answer & explanation

Answer: Activation of the intrinsic apoptotic pathway due to endoplasmic reticulum stress

Answer

Activation of the intrinsic apoptotic pathway due to endoplasmic reticulum stress

The correct answer identifies that the intrinsic apoptotic pathway is activated by endoplasmic reticulum (ER) stress. This patient has alpha-1 antitrypsin (AAT) deficiency, characterized by early-onset panacinar emphysema and liver disease. The mutation causes the AAT protein to misfold. Because it cannot be secreted normally, it accumulates within the rough ER of hepatocytes, forming the characteristic PAS-positive, diastase-resistant globules seen on biopsy. This massive accumulation of misfolded protein triggers the unfolded protein response (UPR) to alleviate ER stress. When the UPR is overwhelmed and the degradative capacity of the cell is exceeded, the cell undergoes apoptosis. This is mediated by the intrinsic pathway, involving the release of cytochrome c from the mitochondria and the activation of caspase-9.

Step-by-Step Solution

Analyze the clinical presentation.

The patient is a young male with early-onset obstructive lung disease (emphysema, indicated by decreased DLCO) and concomitant liver involvement.

To formulate an initial differential diagnosis for combined pulmonary and hepatic disease in a young adult.

Interpret the specific liver biopsy findings.

PAS-positive, diastase-resistant globules in periportal hepatocytes are identified.

To confirm the specific etiology of the patient's condition.

Synthesize the findings to establish a diagnosis.

The combination of early-onset panacinar emphysema and PAS-positive, diastase-resistant hepatocyte inclusions is diagnostic of alpha-1 antitrypsin (AAT) deficiency.

To establish the underlying disease process before identifying the cellular mechanism of injury.

Identify the cellular mechanism of liver injury in AAT deficiency.

In AAT deficiency, a genetic mutation (most commonly PiZZ) causes the AAT protein to misfold. Because it cannot be secreted, it accumulates within the rough endoplasmic reticulum (RER) of hepatocytes.

To understand the subcellular location of the pathology.

Determine the cellular adaptation and subsequent injury pathway.

Severe accumulation of misfolded proteins causes endoplasmic reticulum (ER) stress. If the compensatory unfolded protein response (UPR) is overwhelmed, the intrinsic (mitochondrial) pathway of apoptosis is activated, leading to cell death.

To answer the specific question asked in the stem regarding the mechanism of subsequent cell death.

Key Concept

In alpha-1 antitrypsin deficiency, misfolded proteins accumulate in the hepatocyte rough endoplasmic reticulum, leading to ER stress. If unmitigated, this stress activates the intrinsic apoptotic pathway.

Question 133Question →

A $34$ -year-old man is brought to the emergency department by emergency medical services after being found unresponsive in a public restroom. On initial evaluation, his respiratory rate is $6/\text{min}$ and he has pinpoint pupils. He is administered intravenous naloxone, which rapidly improves his respiratory effort and mental status. The patient admits to injecting heroin earlier in the day and expresses a strong desire to enter treatment for his substance use. After observing the patient for $2$ hours, the physician notes that he appears calm with stable vital signs and minimal objective signs of withdrawal. To initiate medication-assisted treatment for opioid use disorder before discharge, the physician administers a dose of sublingual buprenorphine. Within $20$ minutes, the patient becomes extremely agitated, diaphoretic, and tachycardic. He complains of severe diffuse muscle aches, nausea, and abdominal cramps. Which of the following pharmacodynamic properties of the newly administered medication best explains this patient's acute deterioration?

Irreversible, noncompetitive antagonism at the receptor

Accelerated hepatic elimination of the prior substance via enzyme induction

High receptor affinity and low intrinsic efficacy

Direct activation of central alpha-2 adrenergic receptors

Rapid downregulation of receptor density following acute exposure

Show answer & explanation

Answer: High receptor affinity and low intrinsic efficacy

Answer

High receptor affinity and low intrinsic efficacy

The correct answer accurately describes the unique pharmacodynamic profile of buprenorphine: high receptor affinity and low intrinsic efficacy. Buprenorphine is a partial agonist at the mu-opioid receptor. It possesses a significantly higher binding affinity for this receptor than most full agonists, such as heroin (and its active metabolites, including morphine) or methadone. When buprenorphine is administered to a patient who still has a full agonist occupying the mu-opioid receptors (even if they appear clinically stable or are experiencing only minimal withdrawal), the buprenorphine competitively and aggressively displaces the full agonist. Because buprenorphine is only a partial agonist (meaning it activates the receptor to a lesser maximal extent), the net effect is a sudden, sharp decrease in opioid receptor signaling. This precipitous drop in receptor stimulation triggers severe, acute opioid withdrawal symptoms, a phenomenon known as precipitated withdrawal.

Step-by-Step Solution

Identify the patient's acute clinical presentation after receiving the new medication.

The patient rapidly developed agitation, diaphoresis, tachycardia, and muscle aches, which collectively represent the classic toxidrome of acute precipitated opioid withdrawal.

Recognizing the clinical syndrome is the mandatory first step to working backward to the underlying molecular mechanism.

Analyze the pharmacology of the administered drug compared to the patient's previously used substance.

Heroin (and its active metabolites) acts as a full agonist at the mu-opioid receptor. Buprenorphine is a partial agonist with very high binding affinity but lower intrinsic activity compared to full agonists.

Comparing the receptor properties of both substances explains their interaction when present at the receptor site simultaneously.

Determine the net effect at the receptor level when the new medication is introduced to an occupied receptor system.

Due to its high affinity, the medication competitively displaces residual full agonists from the mu-opioid receptors. Because of its low intrinsic efficacy, the overall receptor activation drops precipitously, triggering the acute withdrawal symptoms.

This specific pharmacodynamic interaction perfectly matches the rapid onset and severity of the patient's deterioration.

Key Concept

Buprenorphine is a partial mu-opioid agonist with high receptor binding affinity and low intrinsic efficacy; administering it while a full agonist is still present on the receptors displaces the full agonist, precipitously lowering net opioid signaling and triggering acute withdrawal.

Question 134Question →

Pathologic changes at the cellular level present uniquely depending on the inciting stressor and the specific tissue involved. Match each patient's clinical and pathologic presentation with the underlying cellular injury or adaptation mechanism responsible for the observed findings.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Myocardial infarction matches with protein denaturation (coagulative necrosis); ischemic stroke matches with enzymatic digestion (liquefactive necrosis); systemic lupus erythematosus with malignant hypertension matches with immune complex accumulation (fibrinoid necrosis); breast trauma matches with triglyceride breakdown (fat necrosis); GERD matches with stem cell reprogramming (metaplasia).

Each clinical scenario corresponds to a unique morphologic pattern of cellular adaptation or cell death. The heart undergoes coagulative necrosis due to ischemia (characterized by protein denaturation). The brain undergoes liquefactive necrosis due to ischemia (characterized by enzymatic digestion). Small vessels undergo fibrinoid necrosis in malignant hypertension (characterized by plasma protein leakage). Breast tissue undergoes fat necrosis after trauma (characterized by saponification). The esophagus undergoes metaplasia in response to GERD (characterized by stem cell reprogramming).

Step-by-Step Solution

Analyze the myocardial infarction case.

Identified as coagulative necrosis.

Ischemic necrosis in most solid organs (except the brain) causes widespread protein denaturation, preventing autolysis and preserving cellular architecture.

Analyze the ischemic stroke case.

Identified as liquefactive necrosis.

The brain is a notable exception to ischemic coagulative necrosis; hypoxia in the CNS leads to rapid enzymatic digestion by microglial cells, resulting in cyst formation.

Analyze the malignant hypertension case.

Identified as fibrinoid necrosis.

Severe acute hypertension or vasculitis damages the vascular endothelium, allowing plasma proteins and immune complexes to leak into and destroy the vessel wall.

Analyze the breast trauma case.

Identified as fat necrosis.

Physical trauma to fatty tissue causes adipocyte destruction and saponification, which is the process of calcium binding to free fatty acids.

Analyze the GERD case.

Identified as metaplasia.

Chronic mucosal irritation induces the replacement of the native squamous epithelium with a more resilient columnar cell type through local stem cell reprogramming.

Key Concept

Cellular injury manifests as distinct morphological patterns of necrosis (coagulative, liquefactive, fibrinoid, fat) depending on the tissue and inciting event, while cellular adaptation to chronic stress often involves reversible changes such as metaplasia.

Estimated Time:2m 0s

Question 135Question →

A 76-year-old man with a 25-year history of poorly controlled essential hypertension and osteoarthritis dies from complications of a massive subarachnoid hemorrhage. Postmortem examination reveals a markedly enlarged heart with concentric left ventricular thickening. Light microscopy of the myocardium demonstrates widened myocytes containing enlarged, hyperchromatic 'boxcar' nuclei. High-power examination of these cells reveals the presence of a finely granular, yellow-brown perinuclear pigment. This pigment is strongly positive for Sudan Black B and periodic acid-Schiff (PAS) staining, but it is negative for Prussian blue staining. Which of the following pathophysiologic processes is most directly responsible for the accumulation of this intracellular material?

Lysosomal accumulation of degraded iron-storage macromolecular complexes

Extracellular aggregation of misfolded polypeptides in a beta-pleated sheet conformation

Autophagic sequestration of free radical-peroxidized subcellular membranes

Massive cytosolic calcium influx with activation of endogenous phospholipases

Unregulated activation of the coagulation cascade resulting in microvascular ischemic damage

Show answer & explanation

Answer: Autophagic sequestration of free radical-peroxidized subcellular membranes

Answer

Autophagic sequestration of free radical-peroxidized subcellular membranes

The correct answer accurately describes the formation of lipofuscin. The vignette describes a patient with long-standing hypertension leading to left ventricular hypertrophy (enlarged myocytes with 'boxcar' nuclei). The yellow-brown, perinuclear pigment that is Sudan Black B positive (indicating lipid content) and Prussian blue negative (indicating lack of iron) is lipofuscin. Lipofuscin is an insoluble wear-and-tear pigment composed of polymers of lipids and phospholipids complexed with protein. It results from free radical-catalyzed lipid peroxidation of subcellular membranes and accumulates within autophagolysosomes of long-lived cells (like cardiomyocytes and neurons) as a marker of cellular aging.

Step-by-Step Solution

Identify the primary pathological finding from the biopsy description.

The presence of widened myocytes with 'boxcar' nuclei indicates cellular hypertrophy. The key finding to identify is the yellow-brown perinuclear pigment.

Establishing the nature of the intracellular material is required to determine its underlying mechanism.

Differentiate the pigment based on its histochemical staining profile.

The pigment is Sudan Black B positive (indicating lipid content) and Prussian blue negative (ruling out iron/hemosiderin). This profile confirms it is lipofuscin.

Different yellow-brown pigments (e.g., lipofuscin, hemosiderin, melanin) have distinct compositions and causes.

Determine the pathophysiologic origin of lipofuscin.

Lipofuscin forms via free radical-induced lipid peroxidation of subcellular membranes, which undergo autophagocytosis.

Connecting the identified pigment to its subcellular mechanism of formation directly answers the question.

Key Concept

Lipofuscin formation via lipid peroxidation in cellular aging and adaptation

Question 136Question →

A 42-year-old man with no history of tobacco use is referred to a pulmonologist for progressive exertional dyspnea that has worsened over the past two years. Pulmonary function tests demonstrate an obstructive pattern that does not improve with inhaled bronchodilators. High-resolution computed tomography of the chest reveals widespread emphysematous changes predominantly affecting the lower lung zones. A comprehensive metabolic panel is notable for mildly elevated aspartate and alanine aminotransferases. To further evaluate the liver abnormalities, a percutaneous liver biopsy is performed. Microscopic examination of the tissue reveals round, eosinophilic globules within the cytoplasm of periportal hepatocytes. These inclusions stain intensely with periodic acid-Schiff (PAS) and resist digestion with diastase. Which of the following best describes the fundamental cellular mechanism responsible for the hepatocyte inclusions seen in this patient?

Defective polypeptide folding leading to failure of transport from the rough endoplasmic reticulum

Excessive cytosolic storage of complex carbohydrates secondary to an inherited lysosomal hydrolase deficiency

Impaired intracellular coupling of newly synthesized lipids with specific apolipoproteins for export

Accumulation of partially degraded microbial cell wall components within the phagolysosomes of macrophages

Intracellular aggregation of indigestible lipid-protein crosslinks resulting from chronic free radical injury

Show answer & explanation

Answer: Defective polypeptide folding leading to failure of transport from the rough endoplasmic reticulum

Answer

Defective polypeptide folding leading to failure of transport from the rough endoplasmic reticulum

This patient's clinical presentation of early-onset, lower-lobe predominant emphysema combined with liver dysfunction is classic for alpha-1 antitrypsin (AAT) deficiency. The disease is most commonly caused by the PiZZ mutation, which results in a substitution of lysine for glutamate. This single amino acid change causes the newly synthesized AAT protein to misfold. The quality control mechanisms within the cell recognize the misfolded protein, preventing it from leaving the rough endoplasmic reticulum (RER) for the Golgi apparatus. Over time, these misfolded proteins aggregate, leading to the formation of PAS-positive, diastase-resistant globules in the cytoplasm of hepatocytes. The accumulation causes direct cellular stress and injury to the liver, potentially progressing to cirrhosis.

Step-by-Step Solution

Analyze the patient's clinical presentation and imaging findings.

Early-onset, lower-lobe predominant panacinar emphysema in a non-smoker is highly suspicious for alpha-1 antitrypsin (AAT) deficiency.

Identifying the systemic clinical syndrome correctly frames the differential diagnosis for the concurrent hepatic abnormalities.

Interpret the liver biopsy histopathology.

The presence of PAS-positive, diastase-resistant globules in periportal hepatocytes confirms the diagnosis of AAT deficiency.

These specific histochemical staining characteristics successfully differentiate AAT aggregates from glycogen, which is diastase-sensitive.

Link the established diagnosis to the underlying mechanism of cellular injury.

In AAT deficiency, a genetic mutation causes the protein to misfold, preventing its exit from the rough endoplasmic reticulum and leading to pathological intracellular aggregation.

This directly answers the prompt by identifying the precise subcellular etiology of the observed hepatocyte inclusions.

Key Concept

Alpha-1 antitrypsin deficiency causes hepatocellular injury through the accumulation of misfolded proteins within the rough endoplasmic reticulum, leading to PAS-positive, diastase-resistant globules.

Estimated Time:1m 30s

Question 137Question →

Match each patient's clinical and laboratory presentation with the specific underlying pathophysiological or molecular mechanism responsible for their hypercoagulable state.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches are: Heparin resistance matches with decreased serine protease inhibitor (Antithrombin deficiency); failure of aPTT to prolong with activated anticoagulant matches with the missense mutation eliminating a cleavage site (Factor V Leiden); prolonged aPTT not correcting on a mixing study matches with immunoglobulins targeting phospholipid-binding proteins (Lupus Anticoagulant); and elevated Factor II matches with the nucleotide transition in the 3'-UTR (Prothrombin G20210A).

Each clinical scenario distinctly isolates one classic hypercoagulable state. Heparin requires antithrombin (a serine protease inhibitor) to function. Factor V Leiden prevents cleavage by activated Protein C due to an amino acid substitution. Lupus anticoagulant (antiphospholipid syndrome) causes uncorrectable aPTT prolongation in vitro due to antibodies. The Prothrombin G20210A mutation increases mRNA translation, elevating Factor II levels.

Step-by-Step Solution

Analyze the first presentation: Heparin resistance in a pregnant woman.

Identified as Antithrombin III deficiency.

Unfractionated heparin exerts its anticoagulant effect strictly by binding to and enhancing the activity of antithrombin (a serine protease inhibitor). Deficiency of antithrombin renders heparin ineffective.

Analyze the second presentation: Normal aPTT that doesn't prolong when activated Protein C is added.

Identified as Factor V Leiden.

Activated Protein C is an endogenous anticoagulant that cleaves and inactivates Factor Va and VIIIa. In Factor V Leiden, a missense mutation destroys the APC cleavage site on Factor V, causing resistance.

Analyze the third presentation: Prolonged aPTT, no correction on 1:1 mixing study, with recurrent fetal loss.

Identified as Antiphospholipid Syndrome (Lupus Anticoagulant).

Failure to correct on a mixing study indicates an inhibitor (autoantibody) rather than a factor deficiency. These antibodies bind phospholipids in the assay, falsely prolonging the aPTT, but cause thrombosis in vivo.

Analyze the fourth presentation: Elevated Factor II (Prothrombin) levels causing unprovoked VTE.

Identified as Prothrombin G20210A mutation.

This specific mutation in the 3'-untranslated region (3'-UTR) of the prothrombin gene prevents normal mRNA degradation, resulting in increased translation and circulating levels of prothrombin.

Key Concept

Understanding the precise molecular pathophysiology and resulting laboratory profiles of the primary inherited and acquired thrombophilias.

Question 138Question →

A 71-year-old man with a history of a mechanical aortic valve replacement presents to the hospital with two weeks of low-grade fever, fatigue, and night sweats. Physical examination reveals a new early diastolic murmur and small, tender erythematous nodules on the pads of his fingers. Transesophageal echocardiography demonstrates an oscillating 0.8-cm vegetation on the prosthetic valve. Multiple blood cultures grow *Enterococcus faecalis*. Susceptibility testing indicates the isolate is susceptible to ampicillin but demonstrates high-level resistance to gentamicin. Consequently, the planned synergistic regimen of ampicillin and gentamicin is abandoned, and he is treated with ampicillin and ceftriaxone. Which of the following best describes the molecular mechanism responsible for this isolate's high-level resistance to gentamicin?

Covalent modification of the antimicrobial molecule via enzymatic transfer of functional groups

Target-site alteration of the 30S ribosomal subunit via chromosomal mutation

Active cellular extrusion of the drug via upregulated transmembrane efflux pumps

Substitution of a terminal amino acid in cell-wall structural precursor peptides

Decreased intracellular drug accumulation secondary to outer membrane porin deletion

Show answer & explanation

Answer: Covalent modification of the antimicrobial molecule via enzymatic transfer of functional groups

Answer

The correct answer is covalent modification of the antimicrobial molecule via enzymatic transfer of functional groups.

The correct answer is covalent modification of the antimicrobial molecule via enzymatic transfer of functional groups. Enterococci exhibit intrinsic low-level resistance to aminoglycosides due to their thick peptidoglycan cell wall, which limits drug uptake. This intrinsic barrier is typically overcome by combining the aminoglycoside with a cell-wall active agent (e.g., ampicillin, penicillin, or vancomycin) to achieve synergistic bactericidal activity. However, some enterococci acquire high-level aminoglycoside resistance (HLAR), which abolishes this synergistic effect. For gentamicin, HLAR is almost exclusively mediated by the acquisition of mobile genetic elements (plasmids or transposons) encoding aminoglycoside-modifying enzymes (AMEs). Specifically, a bifunctional enzyme, AAC(6')-Ie-APH(2'')-Ia, covalently alters the gentamicin molecule via acetylation and phosphorylation. This structural modification severely reduces the drug's binding affinity for its target on the bacterial 30S ribosomal subunit.

Step-by-Step Solution

Analyze the clinical scenario and the specific pathogen.

The patient has infective endocarditis caused by Enterococcus faecalis.

Identifying the pathogen is the first step to determining species-specific resistance mechanisms.

Identify the pharmacological principle underlying the treatment regimen.

Standard therapy involves a cell-wall active agent (ampicillin) plus an aminoglycoside (gentamicin) to achieve bactericidal synergy.

Enterococci have intrinsic low-level resistance to aminoglycosides due to their thick peptidoglycan wall; ampicillin facilitates aminoglycoside cellular entry.

Determine the molecular basis for the high-level resistance noted in the laboratory report.

High-level aminoglycoside resistance (HLAR) to gentamicin abolishes synergy and is mediated by plasmid-encoded aminoglycoside-modifying enzymes (AMEs).

AMEs covalently attach functional groups (e.g., acetyl, adenyl, phosphoryl groups) to the drug, neutralizing its ability to bind the bacterial ribosome.

Key Concept

High-level aminoglycoside resistance (HLAR) to gentamicin in Enterococcus species is mediated by plasmid-encoded aminoglycoside-modifying enzymes that covalently alter the drug structure, destroying its ability to bind to the 30S ribosomal subunit.

Estimated Time:1m 30s

Question 139Question →

A 67-year-old man is hospitalized in the intensive care unit for ventilator-associated pneumonia. Initial endotracheal aspirate cultures grow *Pseudomonas aeruginosa* that is susceptible to piperacillin-tazobactam, cefepime, ciprofloxacin, and imipenem. The patient is started on intravenous imipenem-cilastatin. He initially improves, but on day 11 of hospitalization, his respiratory status declines, and he requires an increase in ventilator support. His temperature is 38.9°C (102°F), blood pressure is 100/60 mm Hg, and pulse is 110/min. A repeat endotracheal aspirate culture again grows *Pseudomonas aeruginosa*. Susceptibility testing of the new isolate reveals resistance to imipenem, but continued susceptibility to cefepime, piperacillin-tazobactam, and ciprofloxacin. Which of the following is the most likely mechanism for the rapid emergence of antimicrobial resistance in this patient's infection?

Decreased expression of an outer membrane channel protein

Upregulation of a membrane-bound multidrug efflux pump

Derepression of a chromosomal AmpC beta-lactamase

Conformational alteration of a penicillin-binding protein

Acquisition of a plasmid encoding a metallo-beta-lactamase

Show answer & explanation

Answer: Decreased expression of an outer membrane channel protein

Answer

Decreased expression of an outer membrane channel protein

The correct answer identifies that Pseudomonas aeruginosa can rapidly develop selective resistance to imipenem during therapy via the transcriptional downregulation or mutational loss of the outer membrane porin OprD. Because imipenem relies heavily on this specific channel to cross the outer membrane into the periplasmic space, loss of OprD confers imipenem resistance. However, this mechanism leaves the organism susceptible to other classes of antibiotics (such as fluoroquinolones) and other beta-lactams (like cefepime and piperacillin-tazobactam) that do not require OprD for entry.

Step-by-Step Solution

Analyze the susceptibility profile of the initial and repeat cultures.

The initial isolate was fully susceptible. The repeat isolate shows isolated resistance to imipenem, while remaining susceptible to other beta-lactams (cefepime, piperacillin-tazobactam) and fluoroquinolones (ciprofloxacin).

Identifying the specific pattern of acquired resistance is necessary to deduce the underlying molecular mechanism.

Correlate the isolated imipenem resistance with known mechanisms in Pseudomonas aeruginosa.

Imipenem specifically requires the OprD outer membrane porin to enter the periplasmic space of Pseudomonas aeruginosa.

Different antibiotics utilize different entry pathways or targets, leading to distinct resistance phenotypes when those pathways are altered.

Differentiate porin loss from other resistance mechanisms.

Loss of OprD explains the selective imipenem resistance, whereas efflux pumps or metallo-beta-lactamases would confer broader multi-drug resistance.

Ruling out broader mechanisms confirms that outer membrane channel modification is the most accurate explanation.

Key Concept

The primary mechanism for isolated imipenem resistance in Pseudomonas aeruginosa is the loss or decreased expression of the OprD outer membrane porin.

Estimated Time:1m 30s

Question 140Question →

Match each clinical scenario of antimicrobial treatment failure with the primary molecular or cellular mechanism responsible for the pathogen's resistance.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct pairings successfully match each distinct clinical presentation of antibiotic failure to its specific underlying genetic or structural resistance mechanism (e.g., Enterococcus HLAR with modifying enzymes, VISA with thickened cell wall, ESBL with hydrolytic enzymes).

Each clinical scenario highlights a distinct, pathogen-specific mechanism of antimicrobial resistance that maps perfectly to the known molecular pathways of those specific drug classes.

Step-by-Step Solution

Analyze each clinical vignette to identify the pathogen and the specific antibiotic resistance phenotype.

Identified HLAR Enterococcus, VISA, ESBL Klebsiella, porin-deficient Pseudomonas, and macrolide-resistant S. pneumoniae.

Accurate identification of the resistance phenotype is the prerequisite for determining the molecular mechanism.

Correlate each identified phenotype with its primary cellular or molecular mechanism of resistance.

Matched each phenotype to enzymatic modification, structural trapping, hydrolytic cleavage, porin downregulation, and target site methylation respectively.

Understanding the exact structural or genetic adaptation explains why specific antibiotic classes fail in these clinical scenarios.

Key Concept

Molecular mechanisms of antimicrobial resistance in high-yield clinical pathogens.

Estimated Time:2m 30s

PreviousPage 7 / 22Next

Foundational Science and Mechanisms of Disease

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept